Modulation of the Immune Response by the Cholera-like Enterotoxins
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
509-519
Author(s):
Andrea Plant and Neil A. Williams
The Impact of Infection on the Incidence of Autoimmune Disease
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
521-529
Author(s):
T. David C. Thomas, Paola Zaccone, David W. Dunne and Anne Cooke
NKT Cell-Stimulating Synthetic Glycolipids as Potential Therapeutics for Autoimmune Disease
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
561-567
Author(s):
Takashi Yamamura, Katsuichi Miyamoto, Zsolt Illes, Endre Pal, Manabu Araki and Sachiko Miyake
Control of Autoimmune Diseases by the B7-CD28 Family Molecules
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
121-128
Author(s):
Sudarshan Anand and Lieping Chen
Endothelial Expression of MHC Class II Molecules in Autoimmune Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
129-143
Author(s):
Carl Turesson
Endothelial Chemokines in Autoimmune Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
145-154
Author(s):
Kent W. Christopherson II and Robert A. Hromas
Regulation of B Cell Activation by PECAM-1: Implications for the Development of Autoimmune Disorders
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
155-161
Author(s):
Mae-Xhum Wong and Denise E. Jackson
Antibody-Mediated Endothelial Cell Damage Via Nitric Oxide
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
213-221
Author(s):
Y. S. Lin, C. F. Lin, H. Y. Lei, H. S. Liu, T. M. Yeh, S. H. Chen and C. C. Liu
α-Galactosylceramide: Potential Immunomodulatory Activity and Future Application [General Articles]
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
241-252
Author(s):
Yoshihiro Hayakawa, Dale I. Godfrey and Mark J. Smyth
The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
1
Page:
53-74
Author(s):
Patrick Englebienne